Adalimumab in the treatment of refractory non-infectious scleritis: 6-month outcomes.
Bober E, Frain K, Fotuhi M, Virgo J, Hindle E, Ma J, Luis J, Addison P, Okhravi N, Tucker W, Westcott M, Pavesio C, Lee R, Yeung I.
Bober E, et al. Among authors: yeung i.
Eye (Lond). 2024 Feb;38(3):628-630. doi: 10.1038/s41433-023-02725-3. Epub 2023 Sep 25.
Eye (Lond). 2024.
PMID: 37749373
No abstract available.